ArticleScientific reports2020

Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression.

Minyoung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.